Profil bibliographique

Sergio Campoy-Díaz

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

9Publications signalées

5Citations signalées

2Affiliations récentes

Institutions déclarées

Hospital de Viladecans Universitat de Barcelona

Domaines associés

Urinary Bladder and Prostate ResearchMigraine and Headache StudiesAutoimmune Neurological Disorders and TreatmentsCardiovascular Syncope and Autonomic Disorders

Publications récentes

Accès ouvert 2026 articleOpenAlex

Additional file 3 of Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, Javier Casas-Limón et autres

0 citationsFigshare

Accès ouvert 2026 otherOpenAlex

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, Javier Casas-Limón et autres

0 citationsFigshare

Accès ouvert 2026 otherOpenAlex

Additional file 1 of Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, Javier Casas-Limón et autres

0 citationsFigshare

Accès ouvert 2026 otherOpenAlex

Additional file 1 of Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, Javier Casas-Limón et autres

0 citationsFigshare

Accès ouvert 2026 otherOpenAlex

Additional file 2 of Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, Javier Casas-Limón et autres

0 citationsFigshare

Accès ouvert 2026 otherOpenAlex

Additional file 2 of Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, Javier Casas-Limón et autres

0 citationsFigshare

Accès ouvert 2026 articleOpenAlex

Additional file 3 of Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, Javier Casas-Limón et autres

0 citationsFigshare

Accès ouvert 2026 otherOpenAlex

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, Javier Casas-Limón et autres

0 citationsFigshare

Accès ouvert 2025 articleOpenAlex

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Albert Muñoz‐Vendrell, Sergio Campoy-Díaz, Paloma Valín‐Villanueva, Javier Casas‐Limón et autres

5 citationsThe Journal of Headache and Pain

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.